Scholar Rock Holding Corporation
NASDAQ:SRRKBiotechnology
+$0.49 today
- Market cap
- $5.86B
- Beta
- 0.69
- P/E (TTM)
- -14.8
- EPS (TTM)
- -$3.21
Volume 2.77M
Average 1.46M
SRRK Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
Scholar Rock Holding CorporationNASDAQ: SRRK
Depreciation & Amortization · Q3 FY2026 · quarter ended Sep 2026
Depreciation & amortization declines year over year
Q3 FY2026 depreciation & amortization of $258K fell 39.0% year over year, behind the -19.2% change in trailing-twelve-month depreciation & amortization. Sequentially, it fell 13.1% from the prior quarter. Over 3 fiscal years it compounded at -17.8% a year.
Context
- Depreciation & amortization increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -39.0% toward the trailing-twelve-month pace of -19.2%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the cash flow
- Latest · FY2025
- 1.66M USD
- Year-over-year change
- -14.4%
- 4-year CAGR
- -10.9%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.66M | -14.4% |
| FY2024 | 2024-12-31 | 1.94M | -31.9% |
| FY2023 | 2023-12-31 | 2.84M | -4.8% |
| FY2022 | 2022-12-31 | 2.99M | +13.7% |
| FY2021 | 2021-12-31 | 2.63M | — |
Depreciation & Amortization vs competitors
How SRRK compares with its peers on the latest reported figures
- SRRK's LTM Sep 2026 depreciation & amortization of $1.32M is the smallest of the 11 companies compared; the peer median is $3.71M.
- Its year-over-year change of -19.2% is the 10th highest of 11, against a peer median of +5.2%.
- Depreciation & amortization amounts to 230.7% of revenue for SRRK, versus a peer median of 5.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $55.3M | +97.1% | -33.0% | 5.5% | |
| LTM Mar 2026 | $45.14M | +15.9% | +2.1% | 2.1% | |
| LTM Sep 2026 | $28.19M | +36.7% | +0.9% | 2.9% | |
| LTM Jun 2026 | $22.24M | +1.2% | +16.4% | 14.3% | |
| LTM Jun 2026 | $5.07M | -7.9% | -7.1% | 0.7% | |
| LTM Sep 2026 | $2.35M | +1.4% | +61.5% | — | |
| LTM Sep 2026 | $2.32M | -9.6% | +21.9% | — | |
| LTM Mar 2026 | $2.28M | +9.0% | +4.6% | 7.1% | |
| LTM Mar 2026 | $2.16M | -28.6% | -14.3% | 10.8% | |
| LTM Jun 2026 | $2.15M | +13.8% | +6.8% | — | |
| LTM Sep 2026 | $1.32M | -19.2% | -17.8% | 230.7% | |
| Peer median (excluding SRRK) | $3.71M | +5.2% | +3.3% | 5.5% | |
Competitors are the stored peer set for SRRK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (131.8M) | (134.5M) | (165.79M) | (246.29M) | (377.94M) |
| Depreciation & Amortization | 2.63M | 2.99M | 2.84M | 1.94M | 1.66M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 23.15M | 27.7M | 27.14M | 36.63M | 75.6M |
| Change in Working Capital | (28.44M) | (34.39M) | (10.61M) | 6.59M | (1.05M) |
| Accounts Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 1.02M | (251K) | (529K) | 6.63M | 208K |
| Other Working Capital | (29.46M) | (34.14M) | (10.09M) | (36K) | (1.26M) |
| Other Non-Cash Items | 7.67M | 5.51M | 1.19M | 186K | 1.7M |
| Operating Cash Flow | (126.79M) | (132.69M) | (145.23M) | (200.95M) | (300.04M) |
| Capital Expenditures | (5.25M) | (1.06M) | (71K) | (98K) | (602K) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | (60.44M) | (300.63M) | (290.8M) | (293.16M) | (98.01M) |
| Sales of Investments | 200M | 130M | 332M | 217.2M | 317.3M |
| Other Investing Activities | 0 | 0 | 13K | 0 | 0 |
| Investing Cash Flow | 134.32M | (171.7M) | 41.14M | (76.06M) | 218.69M |
| Debt Repayment | 24.98M | (975K) | 0 | 0 | 49.14M |
| Common Stock Issued | 13.1M | 195.32M | 97.71M | 324.41M | 179.26M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 6.87M | 492K | 4.87M | 28.61M | 0 |
| Financing Cash Flow | 44.95M | 194.83M | 102.57M | 353.03M | 228.4M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | (2K) |
| Net Change in Cash | 52.48M | (109.56M) | (1.51M) | 76.02M | 147.05M |
| Free Cash Flow | (132.04M) | (133.76M) | (145.3M) | (201.05M) | (300.64M) |
Scholar Rock Holding Corporation
NASDAQ:SRRK
Intrinsic Alpha fair value
Locked
Current Price
$48.00
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.